Yuanying N. Jiang

No.1239 Siping Road
Shanghai, 200092, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 100 publications

NT-A9, a new triazole, exhibits potent antifungal activity against Candida and Cryptococcus species through potent ergosterol biosynthesis inhibition.

NT-A9, a new triazole, exhibits potent antifungal activity against Candida and Cryptococcus species through potent ergosterol biosynthesis inhibition.

Journal: Antimicrobial agents and chemotherapy

Published: August 05, 2026

Design, synthesis, and antibacterial activity study of pyrroloquinazoline diamine derivatives.

Design, synthesis, and antibacterial activity study of pyrroloquinazoline diamine derivatives.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: June 24, 2026

Disruption of the UPC2 Gene Enhances Fluconazole Antifungal Activity by Inhibiting HAC1 mRNA Splicing in Candida albicans.

Disruption of the UPC2 Gene Enhances Fluconazole Antifungal Activity by Inhibiting HAC1 mRNA Splicing in Candida albicans.

Journal: Pathogens (Basel, Switzerland)

Published: April 24, 2026

Recombinant subunit vaccines against invasive fungal infections: mechanisms, development progress, and therapeutic potential.

Recombinant subunit vaccines against invasive fungal infections: mechanisms, development progress, and therapeutic potential.

Journal: Vaccine

Published: March 24, 2026

Pramocaine hydrochloride potentiates fluconazole against Candida albicans biofilms by targeting Erg12 and inhibiting ubiquinone biosynthesis.

Pramocaine hydrochloride potentiates fluconazole against Candida albicans biofilms by targeting Erg12 and inhibiting ubiquinone biosynthesis.

Journal: Biochemical pharmacology

Published: March 16, 2026

Evaluation of in vitro and in vivo antifungal activities of a deuterated tetrazole-based CYP51 inhibitor.

Evaluation of in vitro and in vivo antifungal activities of a deuterated tetrazole-based CYP51 inhibitor.

Journal: Bioorganic chemistry

Published: March 14, 2026

Antisense Oligonucleotides: Technological Advances, Clinical Progress, and Expanding Therapeutic Frontiers.

Antisense Oligonucleotides: Technological Advances, Clinical Progress, and Expanding Therapeutic Frontiers.

Journal: Pharmaceutics

Published: March 11, 2026

Body temperature drives azole tolerance in Candida albicans by hindering the autophagic degradation of Erg11.

Body temperature drives azole tolerance in Candida albicans by hindering the autophagic degradation of Erg11.

Journal: Microbiological research

Published: December 20, 2025

Novel aminoguanidine derivatives containing alkynyl moiety: synthesis and evaluation of antibacterial and antifungal activities.

Novel aminoguanidine derivatives containing alkynyl moiety: synthesis and evaluation of antibacterial and antifungal activities.

Journal: Molecular diversity

Published: December 05, 2025

A dual-targeting antimicrobial agent: Discovery and mechanism of action of a novel 7H-Pyrrolo[3,2-f]quinazoline-1,3-diamine compound.

A dual-targeting antimicrobial agent: Discovery and mechanism of action of a novel 7H-Pyrrolo[3,2-f]quinazoline-1,3-diamine compound.

Journal: Bioorganic chemistry

Published: November 11, 2025

Design, synthesis and evaluation of antifungal activity of 8-hydroxyquinolin-5-ylidene thiosemicarbazone derivatives.

Design, synthesis and evaluation of antifungal activity of 8-hydroxyquinolin-5-ylidene thiosemicarbazone derivatives.

Journal: Current research in microbial sciences

Published: August 01, 2025

Galactose Inhibits the Translation of Erg1 that Enhances the Antifungal Activities of Azoles Against Candida albicans.

Galactose Inhibits the Translation of Erg1 that Enhances the Antifungal Activities of Azoles Against Candida albicans.

Journal: Antibiotics (Basel, Switzerland)

Published: June 07, 2025

Showing 1-12 of 100

Last Updated: 09/26/2026